The co-located agenda will be announced soon. It will likely include GE Heatlthcare, Siemens, Jabil, Microsoft, Williot, Ypsomed, Neurosoft, ZSK, Myant, DiPulse, Mas Holding, Sony, Trelleborg, Medtronics, Sony, Abbott, imec, Holst, Henkel, DuPont, Quad Industries, Wise SRL, Eastprint, Mekoprint, InnovationLab, Joanneum Research, Liquid Metal, nutromics, IDUN Technologies, Screentec, Loomia, Uni of California, University of Newcastle, Robert Sauvé Research Institute for Occupational Health and Safety, General Silicones Co., Ltd. , etc
Smart Keypads making Integration Easier, Customizable & Versatile
ASADA MESH CO., LTD
Understanding Surface Treatments for PET Substrates.
This initial study compared Print Resolution, Adhesion and Electrical Resistance of different PET substrate manufacturers. We looked at how each company applies their surface treatment and how it impacts the aforementioned variables.
Smart Health Patch 2.0 -
Enabling the next generation of multifunctional medical skin patches with printed electronics (joint talk)
Smart Healthcare demands smart medical devices.
Wearable skin patches allow for comprehensive patient monitoring at medical grade accuracy, improving patient care to become more individualized and connected. Printed Electronics technology is a key enabler to smart health patches - allowing the creation of thin, flexible and lightweight sensing components and full solutions that increase the comfort of wear while allowing long-term vital sight monitoring.
Throughout this presentation Henkel Printed Electronics and Accensors will showcase latest printed electronic materials and sensing technologies to shape the next generation of smart health patches.
Chief Science & Research Officer
Medical Reliable Cardiovascular Health Monitoring Using New Wearable Technology
Current wearable sensor technologies provide limited and less reliable health parameters based mainly on heart rate measurement. Any reliable cardiovascular health assessment requires blood pressure measurements. Many attempts had been made to provide blood pressure measurements using commercially available wearable sensors like in smart watches. However, all attempts failed in measuring blood pressure as required by medical standards. On the other hand, FDA cleared Cardiex\AtCor medical technology became the ‘gold standard’ in measuring non-invasively heart and arterial pressure parameters reflecting cardiac and arterial health.
The challenge is to adapt such medical technology into the wearable sensor devices. This involves examining different and new sensors. It also involve new methods of sensor signals based on cardiovascular physiology to extract clinically significant central arterial pressure parameters. This presentation will review current health wearable technologies, challenges in providing reliable cardiovascular health assessment, and Cardiex current development of medical wearable devices to provide clinical heart and arterial health assessments.
Flexible & 3D Electronics for Connected Medical Devices.
DuPont Microcircuit Materials
Facilitating Wellness throughout the Human Life Cycle through Next Generation Wearables and Sensors
Ensuring health and wellness is crucial for quality of life and longevity. Join us in a discussion how wearable technology and sensors are being created to monitor and report health throughout the human life cycle. Facilitating the human story of health and wellness from womb to late adulthood.
Director of Medical Sales
Mass Producing Wearable Biosensors: Success Stories and Case Studies
Co-Founder & CEO
Smart Insoles for Clinical Research : a Problem-Solving Approach to Deliver Value with Continuous Mobility Assessment
Bringing a drug to market is long and difficult. Studies estimate that the clinical trial process lasts 9 years and costs $1.3B on average. Clinical trials are conducted in multiple phases, with cost and complexity increasing from Phase I to Phase III. Despite the time and capital invested in trials, only 1 in 10 drugs that enter Phase I of a clinical trial will be approved by the FDA.
There is Large medical need to evaluate to treat the physical deterioration of physical status. A growing number of patients with mobility impairments lacks accurate tools to diagnose, monitor expensive evolutive diseases and intervene efficiently.
Gait is the simplest and most actionable biomarker to monitor multiple diseases but vastly underutilized as a biomarker or outcome measure because gait analysis is often not high quality when assessed in the clinic.Clinical gait tests, today, are used to identify mobility disorders, measure the efficacy of a therapeutic treatment. This is done in a controlled setting at sites. However, the technologies or design used present strong limitations. Episodic assessments, sometimes observational, don't generate sufficient sensitive data to demonstrate subtle changes.
The FeetMe solution allows the collection of validated gait data at site with the Insoles, and in the same accurate way in the patients daily life allowing continuous recording of gait data.
Engineering Director, Stretchable Electronics, Co-Founder
Hands on Detection (HOD) functionality for Advanced Driver Assistance Systems (ADAS) enabled by stretchable electronics
The automotive industry is changing extremely fast, and there are opportunities that the stretchable electronics brings to address the challenges that the automotive industry is facing today and in the future.
In this presentation, Forciot and Gentherm, will elaborate on how they see stretchable electronics revolutionizing the automotive interior business and solutions by explaining the benefits from the steering wheel Hands on Detection (HOD) solution perspective.
Forciot’s advanced sensor technology can be integrated into vehicle interiors. With Gentherm, Forciot is cooperating on a solution relating to steering wheel HOD functionality for Advanced Driver Assistance Systems (ADAS).